Considerations for the analysis of longitudinal electronic health records linked to claims data to study the effectiveness and safety of drugs.
about
Using Rich Data on Comorbidities in Case-Control Study Design with Electronic Health Record Data Improves Control of Confounding in the Detection of Adverse Drug ReactionsWhen and how can real world data analyses substitute for randomized controlled trials?Comparison of outcomes following a switch from a brand to an authorized vs. independent generic drug.Prediction Score for Anticoagulation Control Quality Among Older Adults.Big Data's Role in Precision Public Health.
P2860
Considerations for the analysis of longitudinal electronic health records linked to claims data to study the effectiveness and safety of drugs.
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Considerations for the analysi ...... ctiveness and safety of drugs.
@ast
Considerations for the analysi ...... ctiveness and safety of drugs.
@en
type
label
Considerations for the analysi ...... ctiveness and safety of drugs.
@ast
Considerations for the analysi ...... ctiveness and safety of drugs.
@en
prefLabel
Considerations for the analysi ...... ctiveness and safety of drugs.
@ast
Considerations for the analysi ...... ctiveness and safety of drugs.
@en
P2860
P356
P1476
Considerations for the analysi ...... ctiveness and safety of drugs.
@en
P2093
S Schneeweiss
P2860
P304
P356
10.1002/CPT.359
P407
P577
2016-02-25T00:00:00Z